0% found this document useful (0 votes)
89 views26 pages

Pe0056700078302325 RLS

Uploaded by

tirthankar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
89 views26 pages

Pe0056700078302325 RLS

Uploaded by

tirthankar
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 26

Name : Keshab Mishra(57Y/M)

Date : 06 Jul 2024

Test Asked : Aarogyam Male With Utsh, Complete Urine Analysis Se + 2


Others
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE PARVATI
TEST ASKED : AAROGYAM MALE WITH UTSH,COMPLETE URINE ANALYSIS APPARTMENT KOLKATA 700040
SE,ESR,FBS

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) 8.48 mg/L <3
COMPLETE HEMOGRAM
BASOPHILS - ABSOLUTE COUNT 0.01 X 10³ / µL 0.02 - 0.1
LYMPHOCYTE 15.7 % 20-40
MEAN CORP.HEMO.CONC(MCHC) 30.8 g/dL 31.5-34.5
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 25.1 pq 27.0-32.0
MEAN CORPUSCULAR VOLUME(MCV) 81.7 fL 83.0-101.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.8 % 11.6-14
COMPLETE URINE ANALYSIS
URINARY GLUCOSE Present 3+(500-1000 mg/dL Absent
mg/dl)
URINARY PROTEIN Present 1+(30-100 mg/dL Absent
mg/dl)
DIABETES
AVERAGE BLOOD GLUCOSE (ABG) 148 mg/dL 90-120
FASTING BLOOD SUGAR(GLUCOSE) 137 mg/dL 70-100
HbA1c 6.8 % < 5.7
IRON DEFICIENCY
IRON 52.05 µg/dL 65 - 175
LIPID
HDL / LDL RATIO 0.34 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 27 mg/dL 40-60
TC/ HDL CHOLESTEROL RATIO 5 Ratio 3-5
TRIG / HDL RATIO 8.01 Ratio < 3.12
TRIGLYCERIDES 214 mg/dL < 150
VLDL CHOLESTEROL 42.89 mg/dL 5 - 40
OTHER COUNTS
ERYTHROCYTE SEDIMENTATION RATE (ESR) 35 mm / hr 0 - 15
PANCREATIC
AMYLASE 132.55 U/L 28 - 100
LIPASE 127.06 U/L 5.6 - 51.3
RENAL
CREATININE - SERUM 1.54 mg/dL 0.72-1.18

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE PARVATI
TEST ASKED : AAROGYAM MALE WITH UTSH,COMPLETE URINE ANALYSIS APPARTMENT KOLKATA 700040
SE,ESR,FBS

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
EST. GLOMERULAR FILTRATION RATE (eGFR) 49 mL/min/1.73 m2 >= 90
URIC ACID 10.32 mg/dL 4.2 - 7.3
TOXIC ELEMENTS
BERYLLIUM 0.08 µg/L 0.10 - 0.80

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
REF. BY : SELF
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : COMPLETE URINE ANALYSIS

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.


Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.01 - 1.003-1.030
PH pH indicator 6 - 5-8
Chemical Examination
URINARY PROTEIN Protein error Present 1+(30-100 mg/dL Absent
mg/dl)
URINARY GLUCOSE GOD-POD Present 3+(500-1000 mg/dL Absent
mg/dl)
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy ABSENT cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT
PARASITE Microscopy ABSENT

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:55
Report Released on (RRT) : 06 Jul 2024 13:08
Sample Type : URINE
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607040996/PP015
Barcode : CJ312295 Page : 1 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE PARVATI
: SELF
APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.


ARSENIC ICP-MS 1.37 µg/L <5
CADMIUM ICP-MS 0.87 µg/L < 1.5
MERCURY ICP-MS 0.51 µg/L <5
LEAD ICP-MS 32.79 µg/L < 150
CHROMIUM ICP-MS 2.98 µg/L < 30
BARIUM ICP-MS 4.48 µg/L < 30
COBALT ICP-MS 0.22 µg/L 0.10 - 1.50
CAESIUM ICP-MS 3.21 µg/L <5
THALLIUM ICP-MS 0.05 µg/L <1
URANIUM ICP-MS 0.09 µg/L <1
STRONTIUM ICP-MS 20.11 µg/L 8 - 38
ANTIMONY ICP-MS 9.29 µg/L 0.10 - 18
TIN ICP-MS 0.82 µg/L <2
MOLYBDENUM ICP-MS 1.44 µg/L 0.70 - 4.0
SILVER ICP-MS 0.98 µg/L <4
VANADIUM ICP-MS 0.36 µg/L < 0.8
BERYLLIUM ICP-MS 0.08 µg/L 0.10 - 0.80
BISMUTH ICP-MS 0.58 µg/L 0.10 - 0.80
SELENIUM ICP-MS 141.98 µg/L 60 - 340
ALUMINIUM ICP-MS 11.25 µg/L < 30
NICKEL ICP-MS 1.13 µg/L < 15
MANGANESE ICP-MS 14.09 µg/L 7.10 - 20
Please correlate with clinical conditions.

Method :
ICP - MASS SPECTROMETRY
Note:Reference range has been obtained after considering 95% population as cutoff.

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:59
Report Released on (RRT) : 06 Jul 2024 22:34
Sample Type : EDTA Whole Blood
Labcode : 0607041024/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)

Barcode : BD101605 Page : 2 of 23


PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
: SELF
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


HbA1c - (HPLC)
H.P.L.C 6.8 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control


5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 148 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Jul 2024 07:25

Sample Received on (SRT) : 06 Jul 2024 12:59


Report Released on (RRT) : 06 Jul 2024 22:34
Sample Type : EDTA Whole Blood
Labcode : 0607041024/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Barcode : BD101605
Page : 3 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


ERYTHROCYTE SEDIMENTATION RATE (ESR) MODIFIED WESTERGREN 35 mm / hr
Bio. Ref. Interval. :-

Male : 0-15
Female : 0-20

Please correlate with clinical conditions.


Method:- MODIFIED WESTERGREN

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:59
Report Released on (RRT) : 06 Jul 2024 22:34
Sample Type : EDTA Whole Blood
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607041024/PP015
Barcode : BD101605 Page : 4 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.


TOTAL LEUCOCYTES COUNT (WBC) HF & FC 7.45 X 10³ / µL 4.0 - 10.0
NEUTROPHILS Flow Cytometry 76.3 % 40-80
LYMPHOCYTE Flow Cytometry 15.7 % 20-40
MONOCYTES Flow Cytometry 4.8 % 2-10
EOSINOPHILS Flow Cytometry 2.7 % 1-6
BASOPHILS Flow Cytometry 0.2 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) Flow Cytometry 0.3 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT Calculated 5.68 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT Calculated 1.17 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT Calculated 0.36 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT Calculated 0.01 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT Calculated 0.2 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) Calculated 0.03 X 10³ / µL 0-0.3
TOTAL RBC HF & EI 5.45 X 10^6/µL 4.5-5.5
NUCLEATED RED BLOOD CELLS Calculated 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % Flow Cytometry 0.01 % 0.0-5.0
HEMOGLOBIN SLS-Hemoglobin Method 13.7 g/dL 13.0-17.0
HEMATOCRIT(PCV) CPH Detection 44.5 % 40.0-50.0
MEAN CORPUSCULAR VOLUME(MCV) Calculated 81.7 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) Calculated 25.1 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) Calculated 30.8 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) Calculated 42.9 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) Calculated 14.8 % 11.6-14
PLATELET COUNT HF & EI 150 X 10³ / µL 150-410
Remarks : Alert!!! Platelets: Appear adequate in smear.

Clinical history is asked for all the relevant abnormalities detected and in absence / failure of receiving of clinical history,
results are rechecked twice and released. Advised clinical correlation.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:59
Report Released on (RRT) : 06 Jul 2024 22:34
Sample Type : EDTA Whole Blood
Labcode : 0607041024/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Barcode : BD101605 Page : 5 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
: SELF
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 35.3 ng/mL


Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical
for building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%


Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay
VITAMIN B-12 E.C.L.I.A 524 pg/mL
Bio. Ref. Interval. :
Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay
Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Jul 2024 07:25

Sample Received on (SRT) : 06 Jul 2024 12:52


Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Barcode : CI175810
Page : 6 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
: SELF
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 98 mg/dL


Bio. Ref. Interval. :
Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 84 mg/dL
Bio. Ref. Interval. :
Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.9 Ratio
Bio. Ref. Interval. :
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method : Derived from serum Apo A1 and Apo B values
Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Jul 2024 07:25

Sample Received on (SRT) : 06 Jul 2024 12:52


Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Barcode : CI175810
Page : 7 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


FOLATE C.L.I.A 9.2 ng/mL
Bio. Ref. Interval. :-

> 5.38 ng/ml

Clinical Significance: Low folate intake, malabsorption as a result of gastrointestinal diseases, pregnancy, and drugs such as
phenytoin are causes of folate deficiency.3 Folate deficiency is also associated with chronic alcoholism. Serum folate measurement
provides an early index of folate status.

Specifications: Precision: Intra assay (%CV): 7.93, Inter assay (%CV): 7.19, Sensitivity: 0.35 ng/mL.

Kit Validation References: Steinkamp RC. Vitamin B12 and folic acid: clinical and pathophysiological considerations. In: Brewster
MA, Naito HK, eds. Nutritional Elements and Clinical Biochemistry. New York: Plenum Publishing Corp.; 1980:169–240

Please correlate with clinical conditions.


Method:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 8 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 8.48 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk


1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:


1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.


Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 9 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 3.91 mg/dL
Bio. Ref. Interval. :-

Adults : < 30.0 mg/dl

Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.

Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %

Kit Validation Reference:


Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Please correlate with clinical conditions.


Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 10 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


TESTOSTERONE E.C.L.I.A 501 ng/dL
Bio. Ref. Interval. :-

280 - 800

Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males.
Major causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,
Hypopituitarism some types of liver and kidney diseases and critical illness.

Specifications: Precision: Intra assay (%CV): 11.50 %, Inter assay (%CV): 5.70%; Sensitivity: 7 ng/dL.
Kit Validation Reference: Wilson JD Foster DW (Eds) Williams Textbook of Endocrinology 8th Edition WB Saunders Piladelphia
Pennsylvania.

Note : The Biological Reference Range mentioned is specific to the age group and gender. Kindly correlate clinically.

Please correlate with clinical conditions.


Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 11 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


PROSTATE SPECIFIC ANTIGEN (PSA) C.L.I.A 0.58 ng/mL
Bio. Ref. Interval. :-

Normal : < 4.00 ng/ml


Border line : 4.01 to 10.00 ng/ml

Clinical Significance:

Elevated levels of PSA are associated with prostate cancer, but may also be seen with prostatitis (Inflammation of the prostate)
and benign prostatic hyperplasia (BPH). PSA test done along with free PSA provides additional information. Studies have
suggested that the percentage of free PSA in total PSA is lower in patients with prostate cancer than those with benign prostate
hyperplasia.

Specification:

Precision: Intra assay (%CV): 4.38%, Inter assay (%CV): 4.67%; Sensitivity: 0.01 ng/ml

Kit validation references:

Wang MC, Valenzuala LA, Murphy GP, and Chu TM. Purification of a human prostate-specific antigen. Invest. Urol. 1979; 17: 159

Please correlate with clinical conditions.


Method:- TWO SITE SANDWICH IMMUNOASSAY

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 12 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


AMYLASE PHOTOMETRY 132.55 U/L
Bio. Ref. Interval. :-

Adults : 28-100 U/L

Interpretation:
Lipemic Sera (Hypertriglyceridemia) may contain inhibitors, Which falsely depress results. About 20% of patients with Acute
Pancreatitis have abnormal lipids. Normal serum amylase may occur in Pancreatitis, Especially relapsing and chronic pancreatitis.
Moderate increases may be reported in normal pregnancy.

Clinical Significance:
Causes of high Serum Amylase include Acute Pancreatitis, Pancreatic Pseudocyst, Pancreatic Ascites, Pancreatic Abscess,
Neoplasm in or adjacent to Pancreas, Trauma to Pancreas, and common Duct Stones. Nonpancreatic Causes include inflammatory
salivary lesions (Eg, Mumps), Perforated Peptic Ulcer, Intestinal Obstruction, Biliary Tract Disease, Peritonitis, Acute Appendicitis,
Diabetic Ketoacidosis, and Extrapancreatic Carcinomas. Amylase levels more than 25-fold the upper limit of normal are often found
when metastatic tumors produce Ectopic Amylase.

Specifications:
Precision: Intra assay (%CV): 2.82, Inter assay (%CV): 2.49, Sensitivity: 10.9 U/L.

Kit Validation References:


Rauscher, E., et coll., Fresenius Z. Analyt. Chem. 324 (1986) 304-305.

Please correlate with clinical conditions.


Method:- ENZYMATIC COLORIMETRIC TEST

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 13 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
: SELF
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 52.05 µg/dL


Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 330.39 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : Spectrophotometric Assay
% TRANSFERRIN SATURATION CALCULATED 15.75 %
Bio. Ref. Interval. :
13 - 45
Method : Derived from IRON and TIBC values
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 278.34 µg/dL
Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY
Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Jul 2024 07:25

Sample Received on (SRT) : 06 Jul 2024 12:52


Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Barcode : CI175810
Page : 14 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


LIPASE PHOTOMETRY 127.06 U/L
Bio. Ref. Interval. :-

Adults : 5.6 - 51.3 U/L

Interpretation:

For diagnostic purposes, the results should always be assessed in conjunction with the patient’s medical history, clinical
examination and other findings like serum amylase. Serum Lipase is usually normal in patients with elevated serum amylase,
having peptic ulcer, salivary adenitis, inflammatory bowel disease, intestinal obstruction, and macroamylasemia. Lipemic sera may
interfere with results.

Clinical Significance:
High serum Lipase is a specific marker for pancreatitis; after acute pancreatitis the Lipase activity increases within 4-8 hours,
reaches a peak after 24 hours and decreases after 8 to 14 days. However, there is no correlation between the Lipase activity
determined in serum and the extent of damage to the pancreas.

Specifications:
Precision: Intra assay (%CV): 3.35, Inter assay (%CV): 2.46, Sensitivity: 3.5 U/L.

Kit Validation References:


Tietz Nw Et Al. Lipase In Serum - The Elusive Enzyme: An Overview. Clin Chem 1993; 39:746-756.

Please correlate with clinical conditions.


Method:- ENZYMATIC COLORIMETRIC ASSAY

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 15 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE PARVATI
: SELF
APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.


TOTAL CHOLESTEROL PHOTOMETRY 134 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 27 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 78 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 214 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 5 Ratio 3-5
TRIG / HDL RATIO CALCULATED 8.01 Ratio < 3.12
LDL / HDL RATIO CALCULATED 2.9 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.34 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 107.34 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 42.89 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150


BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)

Barcode : CI175810 Page : 16 of 23


PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE PARVATI
: SELF
APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.


ALKALINE PHOSPHATASE PHOTOMETRY 74.2 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.89 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.16 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.73 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 27.22 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 30.42 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 31.47 U/L < 45
SGOT / SGPT RATIO CALCULATED 0.97 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.28 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.12 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.16 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.3 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)

Barcode : CI175810 Page : 17 of 23


PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
: SELF
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS

SODIUM I.S.E 139.25 mmol/L


Bio. Ref. Interval. :
ADULTS: 136-145 MMOL/L
Method : ION SELECTIVE ELECTRODE
POTASSIUM I.S.E 3.85 mmol/L
Bio. Ref. Interval. :
ADULTS: 3.5-5.1 MMOL/L

Clinical Significance :
An abnormal increase in potassium (hyperkalemia)can profoundly affect the nervous system and increase the chance of irregular
heartbeats (arrhythmias), which ,when extreme ,can be fatal. The assay could be affected mildly and may result in anomalous values
if serum samples have heterophilic antibodies, hemolyzed , icteric or lipemic. The concentration of Potassium in a given specimen may
vary due to differences in assay methods, calibration and reagent specificity.
Method : ION SELECTIVE ELECTRODE
CHLORIDE I.S.E 98.4 mmol/L
Bio. Ref. Interval. :
ADULTS: 98-107 MMOL/L

Clinical Significance :
An increased level of blood chloride (called hyperchloremia) usually indicates dehydration, but can also occur with other problems that
cause high blood sodium, such as Cushing syndrome or kidney disease. Hyperchloremia also occurs when too much base is lost from
the body (producing metabolic acidosis) or when a person hyperventilates (causing respiratory alkalosis). A decreased level of blood
chloride (called hypochloremia) occurs with any disorder that causes low blood sodium. Hypochloremia also occurs with congestive
heart failure, prolonged vomiting or gastric suction, Addison disease, emphysema or other chronic lung diseases (causing respiratory
acidosis), and with loss of acid from the body (called metabolic alkalosis).
Method : ION SELECTIVE ELECTRODE
Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Jul 2024 07:25

Sample Received on (SRT) : 06 Jul 2024 12:52


Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Barcode : CI175810
Page : 18 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE PARVATI
: SELF
APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.


BLOOD UREA NITROGEN (BUN) PHOTOMETRY 19.05 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 1.54 mg/dL 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 12.37 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 40.77 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 26.47 Ratio < 52
CALCIUM PHOTOMETRY 8.96 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 10.32 mg/dL 4.2 - 7.3
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)

Barcode : CI175810 Page : 19 of 23


PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE PARVATI
REF. BY : SELF
APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.


TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 95 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 8.7 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 2.48 µIU/mL 0.54-5.30

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay


USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Labcode : 0607075480/PP015 Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Barcode : CI175810 Page : 20 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 49 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.


Method:- CKD-EPI Creatinine Equation

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:52
Report Released on (RRT) : 06 Jul 2024 16:32
Sample Type : SERUM
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075480/PP015
Barcode : CI175810 Page : 21 of 23
PROCESSED AT :
Thyrocare
106, Shreegopal,
Jessore Rd, Madhyamgram
Kolkata-700129

NAME : KESHAB MISHRA(57Y/M) HOME COLLECTION :


REF. BY : SELF FLAT NO 7 2ND FLOOR 40 /15 MOORE AVENUE
PARVATI APPARTMENT KOLKATA 700040
TEST ASKED : AAROGYAM MALE WITH UTSH,BLOOD SUGAR
(F),ESR,COMPLETE URINE ANALYSIS SE

TEST NAME TECHNOLOGY VALUE UNITS


FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 137 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

~~ End of report ~~

Sample Collected on (SCT) : 06 Jul 2024 07:25


Sample Received on (SRT) : 06 Jul 2024 12:48
Report Released on (RRT) : 06 Jul 2024 14:15
Sample Type : FLUORIDE
Dr Sukanya Bagchi MD (Path) Dr Arpita MD (Path)
Labcode : 0607075112/PP015
Barcode : CK521700 Page : 22 of 23
CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333

+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 23 of 23

You might also like